CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $74,198
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$74,198. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-16 | Howe Jill Ann Chief Financial Officer | Purchase | +20,000 | $0.86 | $17K | 45,500 |
| 2026-03-05 | Howe Jill Ann Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +1,050,000 | 1,050,000 | ||
| 2025-03-10 | Howe Jill Ann Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2024-11-26 | Howe Jill Ann Chief Financial Officer | Purchase | +15,000 | $0.59 | $9K | 25,500 |
| 2024-08-16 | Howe Jill Ann Chief Financial Officer | Purchase | +10,500 | $0.89 | $9K | 10,500 |
| 2024-03-07 | Howe Jill Ann Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2023-03-09 | Howe Jill Ann Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2022-11-14 | Howe Jill Ann Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +1,000,000 | 1,000,000 |
Page 1 of 1 · 8 trades